Poor recruitment of CD62L+ naïve T cells into the prostate tumor could drastically affect the local generation of tumor specific T cells that recognize neoantigens, which are produced in response to local immune pressure and play an important role in immune evasion. The gene discussed is SELL; the disease is prostate neoplasm.